BHRT pellets vs creams vs patches: which is best and who offers them?

Short answer

• No single “best” form of BHRT — patches, creams/gels, and pellets each have advantages and trade‑offs. The right choice depends on your medical history (age, clotting risk, uterus status), how steady you want dosing, how quickly you want to be able to change dose, convenience, and your tolerance for procedures or skin reactions. Discuss options with a clinician experienced in menopause/BHRT.

How the three compare (pros/cons)

• Transdermal patches (examples: Vivelle‑Dot, Climara, Alora, Minivelle; combined option: CombiPatch)

  • Pros: predictable steady dosing, less liver first‑pass effect (lower venous thromboembolism risk than oral estrogen for many people), easy to stop/change, widely available and FDA‑regulated.
  • Cons: skin irritation, must change on schedule, many patches deliver estrogen only (you’ll need progesterone if you have a uterus).

• Topical creams/gels/sprays (examples: Estrogel, Divigel, Elestrin, Evamist spray; many compounded estradiol/estriol creams also available)

  • Pros: noninvasive, flexible dosing, some people prefer gels for daily tailoring.
  • Cons: absorption is variable (skin thickness/activity affects dose), risk of transfer to others by skin contact, many over‑the‑counter “bioidentical” creams are unregulated or subtherapeutic, compounded creams lack the same oversight as FDA products.

• Subcutaneous pellets (examples/clinics: BioTE Medical, SottoPelle, some providers using EvexiPEL or compounded pellets)

  • Pros: long‑acting (usually 3–6 months), no daily dosing to remember, steady hormone release for months.
  • Cons: minor procedure required for insertion/removal, limited ability to rapidly adjust or stop dosing if side effects occur, many pellets are compounded (less regulatory oversight), and long‑term comparative safety data are limited.

Safety and evidence notes

• “Bioidentical” refers to hormones identical in chemical structure to human hormones (estradiol, progesterone). Many FDA‑approved products (patches, gels, micronized progesterone (Prometrium) etc.) are bioidentical. Compounded preparations are custom but aren’t reviewed by the FDA for safety/consistency.
• Transdermal routes (patch/gel) are generally associated with a lower risk of blood clots than oral estrogen in many studies. Pellets deliver systemic hormone and the data on clotting and other long‑term risks are less definitive.
• If you still have a uterus, you need progestogen to prevent endometrial hyperplasia/cancer. Progesterone options include micronized progesterone (oral Prometrium), topical progesterone (usually compounded), or an intrauterine device (e.g., Mirena) — discuss pros/cons with your clinician.
• Beware clinics or sellers promising “risk‑free” or “miracle” BHRT; ask for qualifications, labs, and follow‑up plans.

Who offers each, and specific names to consider

• Patches and FDA‑approved gels/sprays (widely prescribed by gynecologists, menopause specialists, and primary care):

  • Vivelle‑Dot (estradiol patch)
  • Climara (estradiol patch)
  • Alora / Minivelle (estradiol patches)
  • CombiPatch (estradiol + micronized progesterone patch)
  • Estrogel, Divigel, Elestrin (estradiol topical gels/creams)
  • Evamist (estradiol transdermal spray)
  • These are available by prescription through regular pharmacies and are provided by board‑certified gynecologists or primary care providers.

• Pellets and pellet clinics:

  • BioTE Medical (large network of practitioners trained in BioTE pellet therapy)
  • SottoPelle (specialty pellet therapy clinics/operators)
  • EvexiPEL (brand name used by some providers)
  • Many independent menopause clinics and compounding‑pharmacy‑affiliated providers also insert compounded pellets.
  • Note: many pellet products are compounded rather than FDA‑approved; check the clinic’s training, sterile technique, and follow‑up plan.

• Compounded creams/compounded pellets:

  • Local accredited compounding pharmacies supply custom creams or pellets on prescription. Ask your clinician to use a reputable, PCAB‑accredited compounding pharmacy.

How to choose a provider/product

• See a board‑certified clinician experienced in menopause (gynecologist, reproductive endocrinologist, or an internist with menopause training).
• Ask about:
  • Why they recommend the form chosen for your medical history.
  • Evidence and risks (VTE risk, breast cancer, cardiovascular risks).
  • How dosing is adjusted and how you’ll be monitored (symptoms, labs).
  • If using compounded products: the pharmacy accreditation and sterility/quality processes.
  • If pellets: the provider’s complication rate, insertion technique, and plan if you have side effects.
• Consider starting with an FDA‑approved transdermal patch or gel (predictable dosing, reversibility) if you want a balance of safety and flexibility. Pellets can be convenient but harder to adjust and have less standardized oversight.

If you’d like, tell me:

• whether you have a uterus, any clotting or breast cancer history, and whether you prefer a low‑maintenance option or the ability to fine‑tune dose quickly — I can then suggest the most suitable form and what brands/providers to ask about in your area.